Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reis

Showing results (351-360 of 415) with videos related to

Pageof 42
Sort By:
Plos One|May 26, 2017
Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)Ahmed AlBadri, Kha Lai, Janet Wei, et al.
Journal of Women'S Health (2002)|August 26, 2009
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)C Noel Bairey Merz, B Delia Johnson, Sarah L Berga, et al.
Zeitschrift Fur Immunitatsforschung. Immunobiology|December 1, 1976
Further population studies of HLA-D alleles in the German population [proceedings]H Grosse-Wilde, B Netzel, W Ruppelt, et al.
International Journal of Cardiology. Heart & Vasculature|April 1, 2020
Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women's Ischemic Syndrome Evaluation study (WISE)Erika Jones, B Delia Johnson, Leslee J Shaw, et al.
Journal of the American College of Cardiology|February 7, 2006
Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) StudyGretchen L Gierach, B Delia Johnson, C Noel Bairey Merz, et al.
Journal of the American College of Cardiology|June 3, 2004
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation StudyChristopher B Arant, Timothy R Wessel, Marian B Olson, et al.
Journal of Alzheimer'S Disease Reports|March 4, 2025
Association of mid-life cardiovascular risk with biomarkers of Alzheimer's disease, neurodegeneration, and white matter hyperintensities: Heart SCORE brain studyAnum Saeed, Yuefang Chang, Justin Swanson, et al.
Circulation|June 18, 2003
Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery diseaseQi Chen, Steven E Reis, Candace Kammerer, et al.
American Heart Journal|August 9, 2005
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery diseaseOscar C Marroquin, Kevin E Kip, Suresh R Mulukutla, et al.
Journal of the American College of Cardiology|February 7, 2006
Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) StudyEileen Handberg, B Delia Johnson, Christopher B Arant, et al.
Pageof 42

Showing results (351-360 of 415) with videos related to

Sort By:
Pageof 42
Plos One|May 26, 2017
Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)Ahmed AlBadri, Kha Lai, Janet Wei, et al.
Journal of Women'S Health (2002)|August 26, 2009
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)C Noel Bairey Merz, B Delia Johnson, Sarah L Berga, et al.
Zeitschrift Fur Immunitatsforschung. Immunobiology|December 1, 1976
Further population studies of HLA-D alleles in the German population [proceedings]H Grosse-Wilde, B Netzel, W Ruppelt, et al.
International Journal of Cardiology. Heart & Vasculature|April 1, 2020
Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women's Ischemic Syndrome Evaluation study (WISE)Erika Jones, B Delia Johnson, Leslee J Shaw, et al.
Journal of the American College of Cardiology|February 7, 2006
Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) StudyGretchen L Gierach, B Delia Johnson, C Noel Bairey Merz, et al.
Journal of the American College of Cardiology|June 3, 2004
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation StudyChristopher B Arant, Timothy R Wessel, Marian B Olson, et al.
Journal of Alzheimer'S Disease Reports|March 4, 2025
Association of mid-life cardiovascular risk with biomarkers of Alzheimer's disease, neurodegeneration, and white matter hyperintensities: Heart SCORE brain studyAnum Saeed, Yuefang Chang, Justin Swanson, et al.
Circulation|June 18, 2003
Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery diseaseQi Chen, Steven E Reis, Candace Kammerer, et al.
American Heart Journal|August 9, 2005
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery diseaseOscar C Marroquin, Kevin E Kip, Suresh R Mulukutla, et al.
Journal of the American College of Cardiology|February 7, 2006
Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) StudyEileen Handberg, B Delia Johnson, Christopher B Arant, et al.
Pageof 42